CLINICAL_TRIALS
trial_result
· 2013-07-18
Clinical Trial Update: Phase II Dose-ranging Study of APD421 in PONV [Phase 2]
Summary
Phase II dose-ranging study of APD421 in postoperative nausea and vomiting has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acacia Pharma Ltd | Conditions: Postoperative Nausea and Vomiting | Phase 2 | Status: COMPLETED | Results posted: 2013-07-18